Impact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFalpha biological therapy in France. [electronic resource]
Producer: 20060414Description: 550-6 p. digitalISSN:- 1297-319X
- Adult
- Antibodies, Monoclonal -- economics
- Arthritis, Rheumatoid -- economics
- Cost of Illness
- Drug Costs
- Etanercept
- Female
- France
- Health Care Costs
- Hospitals, University -- economics
- Humans
- Immunoglobulin G -- economics
- Infliximab
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Recombinant Fusion Proteins -- economics
- Retrospective Studies
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.